Skip to main content
Atrás
Watch Compare

Medicus Pharma Ltd.

Calidad de datos: 83%
También listada como MDCXW Nasdaq
MDCX
Nasdaq Manufacturing Chemicals
$0.45
▼ $0.02 (-4.07%)
Cap. Mercado: 17.61 M
Precio
$0.45
Cap. Mercado
17.61 M
Rango del Día
$0.44 — $0.47
Rango de 52 Semanas
$0.37 — $8.94
Volumen
734,224
Apertura $0.47
Promedio 50D / 200D
$0.89
49.61% below
Promedio 50D / 200D
$1.92
76.71% below

Quick Summary

Puntos Clave

Negative free cash flow of -22.78 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-4043.60%
Below sector avg (-53.41%)
ROIC-2003.07%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio0.92
Interest Coverage-174.08

Valoración

PE (TTM)
-0.37
Above sector avg (-1.48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -0.4 -1.5
P/B — 1.6
ROE % -4043.6 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -47.28 M
ROE -4043.60% ROA -431.55%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -22.78 M
ROIC -2003.07% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.92
Interest Coverage -174.08 Asset Turnover N/A
Working Capital -876,489 Tangible Book Value -910,126
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.37 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -129.36%
Market Cap 17.61 M Enterprise Value 8.94 M
Per Share
EPS (Diluted TTM) -2.74 Revenue / Share N/A
FCF / Share -0.58 OCF / Share -0.58
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 48.17%
SBC-Adj. FCF -24.29 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -47.28 M -11.16 M
EPS (Diluted) -2.74 -1.16
Gross Profit — —
Operating Income -34.36 M -11.18 M
EBITDA — —
R&D Expenses 7.72 M 3.53 M
SG&A Expenses — —
D&A — —
Interest Expense -197,382.0 —
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 10.06 M 5.65 M
Total Liabilities 10.02 M 2.51 M
Shareholders' Equity -67,554.0 3.13 M
Total Debt — —
Cash & Equivalents 8.71 M 4.16 M
Current Assets 9.89 M 5.38 M
Current Liabilities 9.94 M 2.31 M